ArticlemAbs2018

Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma.

Jacob Lund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.